Wartime tactic doubles power of scarce bird-flu drug

被引:21
作者
Butler, D
机构
关键词
All Open Access; Bronze;
D O I
10.1038/438006a
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tamiflu (oseltamivir phosphate) is the main bird flu medicine recommended by WHO. However, eventhough the drug's sole supplier Roche has increased its production capacity, the current supply is just about 2% of the world population. One solution involves administering probenecid in combination, as this can givethe same therapeutic effect at half the dose. However, there seems to be a lack of interest amongst Roche and the relevant authorities in pursuing this approach.
引用
收藏
页码:6 / 6
页数:1
相关论文
共 1 条
[1]   The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion - Correlation of in vivo and in vitro studies [J].
Hill, G ;
Cihlar, T ;
Oo, C ;
Ho, ES ;
Prior, K ;
Wiltshire, H ;
Barrett, J ;
Liu, BL ;
Ward, P .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (01) :13-19